Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
From one-size-fits-all to precision medicine: AI’s impact on pharma Drug develo...
The companies are also launching their first collaboratively developed product, ...
Affecting adults and children, this rare, progressive, genetic disorder impacts ...
Indulekha has announced the successful completion of its second large clinical ...
Global pharma major Lupin announced the launch of Atharv Ability, its world-cla...
Dr Amit Kumar: How can policy frameworks better align commercial interests in t...
The offer was approved by Assertio’s Board of Directors, following a revised mer...
The approval covers adults and adolescents in the European Union (EU) who weigh ...
The facility has received EU GMP certification from the Malta Medicines Authori...
This product would be manufactured at Lupin’s Nagpur facility in India The post...
Assertio is focused on specialty and oncology supportive-care therapies The pos...
AstraZeneca Pharma India has launched K+ Connect, a pan-India multidisciplinary...
Eli Lilly and Company (India) announced the launch of Lormalzi (donanemab, 350 ...
With this authorisation, the UAE is said to become the first nation worldwide to...
The round was led by Thrive Capital, with participation from existing investors ...
India is now well-positioned to introduce a limited, risk-calibrated patent-ter...